earnings
confidence high
sentiment positive
materiality 0.75
Viatris FY23 rev $15.4B, adj EBITDA $5.1B; 2024 guidance; $1B buyback boost; Idorsia deal
Viatris Inc
2023-FY EPS reported
$0.05
revenue$15,426,900,000
- FY23 total revenues $15.4B, U.S. GAAP net earnings $54.7M, adjusted EBITDA $5.1B, free cash flow $2.4B.
- Reports third consecutive quarter of operational revenue growth on divestiture-adjusted basis; expects continued growth in 2024.
- Enters global R&D collaboration with Idorsia for two Phase 3 assets selatogrel and cenerimod with blockbuster potential.
- Board increases share repurchase authorization by $1B to $2B; maintains $0.48 annual dividend, declares $0.12 Q1 dividend.
- Completed $250M in share repurchases in 2024 to date; guidance for 2024 provided.